Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on the in vivo Biological Context
David Sarrió, Alejandro Rojo‐Sebastián, Ana Teijo, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 13

Showing 13 citing articles:

Alternative splicing of GSDMB modulates killer lymphocyte–triggered pyroptosis
Qing Kong, Shiyu Xia, Xingxin Pan, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Open Access | Times Cited: 54
Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells
Sara S. Oltra, Sara Colomo, Laura Sin, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1366-1381
Open Access | Times Cited: 41
Gasdermins: a dual role in pyroptosis and tumor immunity
Jiayi Yang, Jingting Jiang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
The enigmatic roles of epithelial gasdermin B: Recent discoveries and controversies
Andrei I. Ivanov, Nitish Rana, Giuseppe Privitera, et al.
Trends in Cell Biology (2022) Vol. 33, Iss. 1, pp. 48-59
Open Access | Times Cited: 30
Progress in the study of molecular mechanisms of cell pyroptosis in tumor therapy
Dong Wang, Xin Wan
International Immunopharmacology (2023) Vol. 118, pp. 110143-110143
Closed Access | Times Cited: 15
Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation
Manuel Gámez-Chiachio, Ángela Molina-Crespo, Carmen Ramos, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 22
Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs
Manuel Gámez-Chiachio, David Sarrió, Gema Moreno‐Bueno
Cancers (2022) Vol. 14, Iss. 18, pp. 4543-4543
Open Access | Times Cited: 19
Functional Materials Targeted Regulation of Gasdermins: From Fundamentals to Functionalities and Applications
Luyao Tian, Shilong Piao, Xia Li, et al.
Advanced Science (2025)
Open Access
Gasdermin E as a potential target and biomarker for CRISPR-Cas9-based cancer therapy
Mojtaba Tarin, Amir Sh. Saljooghi
Biochemical Pharmacology (2025), pp. 116961-116961
Closed Access
Gasdermins in pyroptosis, inflammation, and cancer
Rui Min, Yang Bai, N. Wang, et al.
Trends in Molecular Medicine (2025)
Closed Access
Cell Death: Mechanisms and Potential Targets in Breast Cancer Therapy
J Qian, Linna Zhao, Ling Xu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9703-9703
Open Access | Times Cited: 3
Gasdermin‐B (GSDMB) takes center stage in antibacterial defense, inflammatory diseases, and cancer
David Sarrió, Sara Colomo, Gema Moreno‐Bueno
FEBS Journal (2023) Vol. 291, Iss. 14, pp. 3060-3071
Open Access | Times Cited: 3
Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells
Sara S. Oltra, Laura Sin, Sara Colomo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Structural and functional insights into GSDMB isoforms complex roles in pathogenesis
Sara Colomo, David Ros‐Pardo, Sara S. Oltra, et al.
Cell Cycle (2023) Vol. 22, Iss. 20, pp. 2346-2359
Closed Access
Page 1

Scroll to top